Viewing StudyNCT02971748



Ignite Creation Date: 2024-05-06 @ 9:25 AM
Last Modification Date: 2024-10-26 @ 12:13 PM
Study NCT ID: NCT02971748
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-01-19
First Post: 2016-11-21

Brief Title: Pembrolizumab in Treating Patients With Hormone Receptor Positive Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-01-26
Start Date Type: ACTUAL
Primary Completion Date: 2024-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2016-11-21
First Submit QC Date: November 22 2016
Study First Post Date: 2016-11-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-13
Last Update Post Date: 2024-01-19
Last Update Post Date Type: ACTUAL